Neuronal Cav3 channelopathies: recent progress and perspectives.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• T-type, low-voltage activated calcium channels (Cav3) are crucial for neuronal excitability, sensory processing, sleep, and neurotransmitter release.
• Genetic studies, including knockout models, have elucidated the physiological roles of Cav3 channels.
• Mutations in Cav3 channel genes (CACNA1G, CACNA1H, CACNA1I) are linked to neurodevelopmental, neurological, and psychiatric disorders, termed Cav3 channelopathies.

Purpose of the Study:

• To review clinical findings and in vitro/in vivo studies of Cav3 channelopathies.
• To focus on de novo, gain-of-function missense mutations in CACNA1G and CACNA1H.
• To elucidate the pathogenic mechanisms underlying Cav3 channelopathies and the physiological roles of Cav3 channels.

Main Methods:

• Review of clinical findings associated with Cav3 channelopathies.
• Analysis of in vitro and in vivo studies on mutant Cav3 channels.
• Focus on genetic studies, including de novo mutations and knockout mouse models.

Main Results:

• Mutations in CACNA1G and CACNA1H genes are associated with specific neurodevelopmental, neurological, and psychiatric conditions.
• De novo, gain-of-function missense mutations in CACNA1G and CACNA1H have been recently identified.
• Studies on mutant channels provide insights into altered neuronal excitability and disease pathogenesis.

Conclusions:

• Cav3 channelopathies represent a group of disorders linked to genetic alterations in Cav3 calcium channels.
• Understanding these channelopathies enhances our knowledge of Cav3 channel function and their role in nervous system disorders.
• Further research into Cav3 channelopathies can inform therapeutic strategies for related neurological and psychiatric conditions.